Hierarchical core-shell nanoplatform with sequential Mn2+/Co2+ release enables dual-track STING amplification and radiosensitization for potent radio-metalloimmunotherapy
Acta Biomaterialia · 2026-09 · 222 · 520-536
DOI: 10.1016/j.actbio.2026.08.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-09. Verfasst von Baiyi Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China. Hauptthemen laut MEDLINE: Immunotherapy, Manganese, Radiation-Sensitizing Agents, Membrane Proteins. Die Arbeit nennt 53 Literaturangaben. Gefördert von: Department of Science and Technology of Hubei Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer immunotherapy is often hindered by the immunosuppressive tumor microenvironment and the inefficient activation of the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway under hypoxic conditions. To address these challenges, we developed a hierarchical core-shell Au@Co-EGCG/Mn-EGCG (ACM) nanoplatform that synergistically integrates radiosensitization with a dual-track STING amplification strategy. Owing to its high-Z gold core and robust catalase-like activity, the ACM nanostructure effectively alleviates tumor hypoxia and maximizes X-ray energy deposition, leading to an intense burst of reactive oxygen species (ROS) and irreparable DNA damage. This synergy in turn triggers potent immunogenic cell death and substantial mitochondrial DNA (mtDNA) leakage. Critically, the hierarchical release of Mn2+ and Co2+ ions within tumor cells establishes a "sequential synergistic cascade": Mn2+ sensitizes cGAS for enhanced DNA recognition, while Co2+ acts as a high-gain amplifier by enhancing the binding affinity of STING for 2', 3'-cyclic GMP-AMP (cGAMP). This molecular relay ignites a systemic surge of pro-inflammatory cytokines, notably IFN-β, effectively converting "cold" tumors into "hot" ones. In vivo, ACM-mediated radiotherapy not only achieves thorough in situ tumor ablation but also elicits a powerful abscopal effect, suppressing distant metastasis through enhanced T-cell infiltration and macrophage repolarization. Collectively, this work establishes a potent radio-metalloimmunotherapy paradigm to overcome radioresistance and systemic cancer progression. STATEMENT OF SIGNIFICANCE: The majority of colorectal cancers are microsatellite stable (MSS) and resistant to immunotherapy due to a "cold" tumor microenvironment. In this study, we introduce a hierarchical core-shell nanoparticle that, upon X-ray irradiation, sequentially releases two metal ions to activate the cGAS-STING pathway cooperatively. Unlike conventional single-agent STING agonists, our design separates the DNA sensitization provided by Mn2+ from the signal amplification driven by Co2+, creating a synergistic cascade that overcomes hypoxia-induced immunosuppression. This dual-track mechanism transforms resistant MSS tumors into immune-responsive "hot" lesions, eliminating primary tumors and suppressing distant metastases. The work establishes a new paradigm of radio-metalloimmunotherapy, offering a translatable strategy to convert radiation into a systemic immune adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China.
- Department of Radiation and Medical Oncology, Hubei Provincial Clinical Research Center for Cancer, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.
- Department of Pulmonary Oncology, Hubei Province Cancer Clinical Study Center, Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan 430071, China.. Electronic address: xuyu@wh…
- Department of Cardiovascular Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan 430071, China; State Key Laboratory of Metabolism and Regulation in Complex Organis…
Förderung
- Department of Science and Technology of Hubei Province
- National Natural Science Foundation of China
Zitieren
APA
Luo, B., Xiang, Q., Xie, Y., Wang, S., Xu, Y., & Tian, J. (2026). Hierarchical core-shell nanoplatform with sequential Mn2+/Co2+ release enables dual-track STING amplification and radiosensitization for potent radio-metalloimmunotherapy. Acta Biomaterialia, 222, 520-536. https://doi.org/10.1016/j.actbio.2026.08.012
Vancouver
Luo B, Xiang Q, Xie Y, Wang S, Xu Y, Tian J. Hierarchical core-shell nanoplatform with sequential Mn2+/Co2+ release enables dual-track STING amplification and radiosensitization for potent radio-metalloimmunotherapy. Acta Biomaterialia. 2026;222:520-536. doi:10.1016/j.actbio.2026.08.012
BibTeX
@article{Luo2026,
author = {Luo, Baiyi and Xiang, Qingming and Xie, Yingling and Wang, Shuo and Xu, Yu and Tian, Jian},
title = {Hierarchical core-shell nanoplatform with sequential Mn2+/Co2+ release enables dual-track STING amplification and radiosensitization for potent radio-metalloimmunotherapy},
journal = {Acta Biomaterialia},
year = {2026},
volume = {222},
pages = {520--536},
doi = {10.1016/j.actbio.2026.08.012}
}
EUVIMED